Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 2008

View Archived Issues

Strong immunosuppression by natural compound improves EAE in mice

New compounds for treating cancer disclosed in recent patent literature

Allergan patent describes new therapeutic agents for glaucoma

New agents for treating neurological disorders reported in recent patents

Mechanism of AMPA receptor antagonist protection against viral encephalomyelitis explored

Topical alpha-linolenic acid demonstrates preclinical activity in dry eye

Multiple targeting yields enhanced preclinical antitumor effects in head and neck cancer

Positive interim data for Sunesis' lead product candidate in platinum-resistant ovarian cancer

Ortho Biotech modifies prescribing information for Procrit following guidance from FDA

Wyeth to conclude collaboration agreement with Curis for Hedgehog agonists in stroke

Oramed successfully completes phase Ib clinical trials of oral insulin capsule

Optimer completes enrollment in phase III clinical trial of prulifloxacin in travelers' diarrhea

DSMB recommends continuation of Opexa's phase IIb TERMS study of Tovaxin in MS

Abbott enters agreement with Genentech, Roche and OSI to develop gene test for Tarceva

Health Canada grants approval to BioMimetic Therapeutics to file DLA for GEM OS1

Monogram signs agreement with Avexa to provide HIV resistance and tropism testing

ChemGenex commences phase II omacetaxine trial in AML patients

M's Science and Eisai enter agreement for sigma receptor agonist SA-4503

European approval of desvenlafaxine in VMS will require more clinical data

FDA Advisory Committee recommends approval of sugammadex

Cerimon and Novartis Pharma enter agreement for proof-of-concept study of Simulect in uveitis

Pharmexa and Ichor enter agreement to codevelop malaria and influenza DNA vaccines

Labopharm initiates phase III clinical trial of tramadol-acetaminophen combination drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...